RAMSAY DAVID A bought HALO
July 1, 2026 · Form 4 insider transaction
RAMSAY DAVID A bought 16,232 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,232
Price
$0.00
Total value
N/A
InsiderRAMSAY DAVID A
RoleDirector
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after16,232
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.